Case Study – OneVoice™ + RightStart™


Company: $3-4B
Therapeutic Area: Neuroscience
Approval Date: 2020
Original Support: Hub Nurses
Expansion with VMS: Late 2021
VMS Products: OneVoice + RightStart


Company: $3-4B
Therapeutic Area: Prostate Cancer
Approval Date: 2020
Original Support: Hub Nurses
Expansion with VMS: Late 2021
VMS Products: OneVoice + RightStart
PROGRAM OVERVIEW
Program objectives:
- Minimize abandonment and maximize compliance and persistence for patients initiating therapy
- Maximize the opportunity to
ensure patients prescribed [PRODUCT] get off to a good start - Elevate the patient support program and establish a new standard of field support for patients
SOLUTION
THE ROLE OF THE FIELD NURSE EDUCATOR

2022 PERFORMANCE